Berirab P 300 IU | 2 ml in 1 PFS

Introduction of Berirab P 300 IU Injection

Berirab P 300 IU Injection is a rabies post-exposure prophylaxis (PEP) vaccine. The active ingredient in Berirab P Injection is human rabies immunoglobulin derived from the blood plasma of screened donors. Berirab P 300 IU Injection is used to prevent the development of rabies in people who have been exposed to the virus through bites, scratches, saliva contact with an infected animal or animal traps that have been licked or bitten by infected animals. Berirab P 300 IU Injection is suitable for use in both adults and children.

Berirab P Injection can cause some adverse effects. If you experience symptoms such as pain, swelling, warmth, sudden shortness of breath, chest pain, numbness or weakness on one side, difficulty speaking or confusion. It is important to contact your doctor or nurse immediately as these may be signs of a blood clot. In addition, if you are scheduled to have blood tests, tell your doctor or nurse that you are taking Berirab P 300 IU Injection as it can temporarily increase the levels of certain antibodies in your blood and affect the results of certain tests. Make sure you tell them when you last took Berirab P 300 IU Injection as this can cause misleading results in blood tests.

Before using Berirab P 300 IU Injection, it is important to tell your doctor or nurse if you have a history of high blood pressure, diabetes, blood clots, vein or artery problems or any other blood-related disorder. It is also important to tell your doctor if you have recently had any vaccinations or plan to have any shortly.

Your doctor or nurse will administer Berirab P 300 IU Injection by injection into a muscle. The exact dosage and administration of Berirab P Injection will depend on, among other things, the patient's clinical condition, age and medical history. It is important to note that Berirab P 300 IU Injection should not be self-administered and should only be taken under the supervision of a healthcare professional.

Uses of Berirab P 300 IU Injection

Berirab P Injection is used to help prevent rabies infection. The Berirab P 300 IU Injection works by activating the body's immune system to produce antibodies that protect against the virus.

Benefits of Berirab P 300 IU Injection

Berirab P 300 IU Injection gives instantaneously safety in opposition to rabies. It is specifically recommended for individuals who have been exposed to the rabies virus, such as through a bite or scratch from an infected animal. On the other hand, Berirab P 300 IU Injection is prescribed in similar cases to ensure effective prevention and treatment.

Berirab P Injection has elevated levels of rabies antibodies that effectively neutralise the virus and prevent its transmission to humans. In addition, Berirab P 300 IU Injection has the potential to reduce the required doses of rabies vaccine, providing a beneficial alternative for individuals who are unable to complete the full vaccination series.

Giving Berirab P Injection immediately after exposure to the rabies virus can greatly improve the chances of survival. This is crucial because rabies is a fatal disease that can be prevented with the help of Berirab P 300 IU Injection. By taking immediate action and using Berirab P Injection, the risk of dying from rabies can be effectively reduced.

Side Effects of Berirab P 300 IU Injection

​​As with all medicines, Berirab P 300 IU may have side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.​

Most Common Side Effects of Berirab P 300 IU Injection

• Arm pain after vaccination
• Fever
• Chills
  

Common Side Effects of Berirab P 300 IU Injection

• Pain
• Swelling
• Warmth
• Sudden shortness of breath
• Chest pain
• Numbness
• Weakness on one side
• Difficulty speaking
• Confusion
  

How to Use Berirab P 300 IU Injection?

The injection of Berirab P 300 IU Injection into a muscle is carried out by your doctor or nurse. The specific dosage and route of administration of Berirab P Injection will be determined based on factors such as the patient's clinical condition, age and medical history. It is important to note that Berirab P 300 IU Injection should not be self-administered and should only be taken under the guidance of a healthcare professional. Ideally, Berirab P Injection should be given as soon as possible within the first 24 hours after exposure to the virus. One dose of Berirab P 300 IU Injection is injected directly into the wound or exposed area and the remaining dose is injected into the muscle.

How Berirab P 300 IU Injection Works?

Berirab P Injection works by providing the body with a high concentration of antibodies specific to the rabies virus. These antibodies can bind to and neutralise the virus, preventing it from infecting cells and causing disease. This Berirab P 300 IU Injection can help to further strengthen the body's immune response to the virus and provide long-term protection.

Safety Advices Berirab P 300 IU Injection

Alcohol

Unsafe

Breastfeeding

Use with Caution

Driving

Safe

Liver

Safe

Kidney

Safe

Pregnancy

Safe

References

1. Human Rabies Immunoglobulin 150 Iu/ml Solution For Injection, Bio Products Laboratory Limited, Dagger Lane, Elstree, Hertfordshire, UK, Product Leaflet 

2. Guidelines On Rabies Prophylaxis, National Rabies Control Programme, Govt. Of West Bengal, India, Available Form 

3. Rabies Immune Globulin Of Human Origin: Preparation And Dosage Determination In Non-exposed Volunteer Subjects, National Library Of Medicine. Available Form 

4. Kedrab, Rabies Immune Globulin (Human) Solution For Wound Infiltration And Intramuscular Injection, Kamada Ltd, Product Leaflet 

5. Rabies Immune Globulin, Human (rig) (rx), Medscape, Available Form